AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21480979
Drug: Melatonin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (50 mg/kg BW)
Trial: 14692930
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy without cold air analgesia
Trial: 7506180
Drug: Nimesulide suspension
RxNorm normalized name: nimesulide Oral Suspension
DrugBank: Nimesulide (DB04743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide suspension (1.5 mg/kg 3 times daily)
Trial: 7506180
Drug: Paracetamol syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol syrup (10 mg/kg 4 times daily)
Trial: 2882288
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (30 mg for children under 5, 60 mg for older children)
Trial: 28472976
Drug: DHEA supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA supplementation (25 mg three times a day for 8 weeks)
Trial: 16430794
Drug: Rofecoxib 50
RxNorm normalized name: rofecoxib 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 50 mg administered perioperatively
Trial: 16430794
Drug: Rofecoxib 50
RxNorm normalized name: rofecoxib 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 50 mg administered only postoperatively
Trial: 10638466
Drug: Total Parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total Parenteral Nutrition (TPN) for 10 days preoperatively and 9 days postoperatively
Trial: 10638466
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no preoperative nutrition, 940 kcal nonprotein plus 85 g amino acids postoperatively)
Trial: 9375889
Drug: 1 mg/day
RxNorm normalized name: Lyllana 0.1 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/day of liquid folic acid
Trial: 1608268
Drug: 5% methanolic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% methanolic leaf extract cream of Solanum chrysotrichum
Trial: 1608268
Drug: Miconazole treatment
RxNorm normalized name: Miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Miconazole treatment (control group)
Trial: 3929513
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone releasing factor (GRF) 100 micrograms
Trial: 28094169
Drug: Intranasal oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal oxytocin (24IU twice daily)
Trial: 21493740
Drug: Icodextrin (ICO)
DrugBank: Icodextrin (DB00702)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Icodextrin (ICO) - treated with 1.5 or 2.0 L of 7.5% icodextrin‐containing solutions
Trial: 21493740
Drug: Glucose (GLU)
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucose (GLU) - treated with 8 L of 1.5% or 2.5% glucose
Trial: 18652267
Drug: Ceramic Primer/LinkmaxHV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceramic Primer/LinkmaxHV (CP/LMHV) with 37% phosphoric acid treatment (PA)
Trial: 18652267
Drug: Monobond S/VariolinkIIHV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monobond S/VariolinkIIHV (MBS/VLIIHV) with 37% phosphoric acid treatment (PA)
Trial: 18652267
Drug: MBS/HB/VLIIHV with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MBS/HB/VLIIHV with various surface treatments
Trial: 18652267
Drug: All combined
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All combined groups of ceramic surface treatment and resin bonding system
Trial: 29889285
Drug: High-dose cytarabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cytarabine in combination therapy (HD-ECM)
Trial: 29889285
Drug: Standard combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard combination therapy (ECM)
Trial: 27321554
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream (CG)
Trial: 21358207
Drug: Weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly docetaxel (30 mg/m² on days 1, 8, and 15; q4w)
Trial: 21358207
Drug: Standard docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard docetaxel (75 mg/m² every 3 weeks; q3w)
Trial: 16616726
Drug: Neuroendocrine hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neuroendocrine hormone responses
Trial: 12682721
Drug: Filgrastim (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filgrastim (1 micro g.kg.24 h) for 10 days as a continuous infusion
Trial: 6738337
Drug: 1 dose
RxNorm normalized name: Ribose 3 GM/1 DOSE Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 dose of 10 mg/kg metrifonate
Trial: 6738337
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of 10 mg/kg metrifonate
Trial: 6738337
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of 10 mg/kg metrifonate
Trial: 30761523
Drug: Racecadotril (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racecadotril (100 mg) - acute administration
Trial: 30761523
Drug: Racecadotril (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racecadotril (100 mg; t.i.d.) - chronic administration for 14 days
Trial: 11751710
Drug: Placebo -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo - acute administration
Trial: 30761523
Drug: Placebo -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo - chronic administration for 14 days
Trial: 29070025
Drug: Daylight photodynamic
RxNorm normalized name: calcium carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daylight photodynamic therapy (DL-PDT)
Trial: 28222225
Drug: Conventional photodynamic
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional photodynamic therapy (C-PDT)
Trial: 27115126
Drug: Lipid-based nutrient
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-based nutrient supplements (LNS) 200 g daily during the first 3 months of ART
Trial: 24961851
Drug: Daily intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily intake of DEHP estimated using the urine volume (UV) model
Trial: 24961851
Drug: Daily intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily intake of DEHP estimated using the urine creatinine-excretion (UCE) model
Trial: 19254119
Drug: Metronidazole 500
RxNorm normalized name: metronidazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 500 mg and Amoxicillin 375 mg, three times a day for 7 days
Trial: 20059413
Drug: Metronidazole and
RxNorm normalized name: metronidazole and diloxanide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole and Amoxicillin
Trial: 18065809
Drug: Atorvastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (80 mg daily for 4 weeks)
Trial: 10225812
Drug: Parenteral gold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral gold salt therapy
Trial: 10225812
Drug: Parenteral gold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral gold salt therapy (withdrawn due to side effects)
Trial: 8876346
Drug: Ginseng (GS)
DrugBank: Ginseng (DB01404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginseng (GS) 8 or 16 mg/kg body weight daily for 7 days
Trial: 31682026
Drug: 1-L PEG
RxNorm normalized name: Peg/L-asparaginase
DrugBank: Pegaspargase (DB00059)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1-L PEG
Trial: 29498469
Drug: vildagliptin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vildagliptin (50 mg twice daily)
Trial: 29498469
Drug: dapagliflozin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dapagliflozin (10 mg once daily)
Trial: 24021029
Drug: SumaRT/Nap (85
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SumaRT/Nap (85 mg sumatriptan + 500 mg naproxen sodium)
Trial: 24020994
Drug: naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: naproxen sodium (500 mg)
Trial: 22503574
Drug: 18 mg
RxNorm normalized name: niacin 18 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18 mg nicotine e‐cigarette
Trial: 22503574
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg e‐cigarette (placebo)
Trial: 15988695
Drug: Hydrocortisone (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (12.5 mg/h IV)
Trial: 9608969
Drug: Scheduled administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scheduled administration of acetaminophen (60 mg.kg-1.24h-1 orally, 90 mg.kg-1.24h-1 rectally)
Trial: 9608969
Drug: Acetaminophen 'as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 'as needed' (control group)
Trial: 7658599
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg recombinant human GH for 7 to 13 days
Trial: 28475943
Drug: Motivational Interviewing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivational Interviewing Treatment Integrity coding system 4.2 (MITI 4.2)
Trial: 21982529
Drug: Fluconazole 200
RxNorm normalized name: fluconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole 200 mg three times per week
Trial: 16522388
Drug: Antibiotic group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic group (oral azithromycin 1 g twice, plus metronidazole 750 mg daily for 7 days)
Trial: 8699051
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of sorivudine
Trial: 1526858
Drug: Daily treatment
RxNorm normalized name: BENZOYL PEROXIDE 2.5 g in 100 g TOPICAL GEL [Acne defense Daily Treatment Serum Merle Norman]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily treatment regimen delivering 2 Gy per fraction
Trial: 1526858
Drug: Once weekly
RxNorm normalized name: Actonel 35 4-Week Once Weekly Dosepack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once weekly treatment regimen delivering 5.4 Gy per fraction
Trial: 29794092
Drug: Gelatine tannate
RxNorm normalized name: Gelatin
DrugBank: Gelatin (DB11242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gelatine tannate (250-500 mg, four times per day for 5 days)
Trial: 24813026
Drug: Duloxetine (60‐120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (60‐120 mg once daily, n=117)
Trial: 24813026
Drug: Fluoxetine (20‐40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20‐40 mg once daily, n=117)
Trial: 20033907
Drug: Atypical antipsychotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atypical antipsychotics (risperidone, olanzapine, aripiprazole)
Trial: 8567844
Drug: Combined leuprolide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined leuprolide (3.75 mg every 27 days) plus conventional therapy (group A)
Trial: 8567844
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy alone (group B)
Trial: 8567844
Drug: GnRHa treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRHa treatment (group C)
Trial: 2358736
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (CT) by injection sclerotherapy or rubber band ligation
Trial: 26383695
Drug: Interactive Behavioural
RxNorm normalized name: Menin-mll interaction inhibitor ko 539
DrugBank: Ziftomenib (DB17171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive Behavioural Modification Therapy (IBMT)
Trial: 19284932
Drug: Both interventions
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both interventions (Nortriptyline and Sertraline)
Trial: 8197035
Drug: Ibuprofen 400
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 400 mg plus paracetamol 325 mg
Trial: 8197035
Drug: Dextropropoxyphene 65
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextropropoxyphene 65 mg plus paracetamol 400 mg
Trial: 3592300
Drug: Propranolol (0.01,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.01, 0.02, 0.03, and 0.04 mg/kg IV)
Trial: 3592300
Drug: Pindolol (0.001,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (0.001, 0.002, 0.003, and 0.004 mg/kg IV)
Trial: 31358477
Drug: Testosterone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (200 mg testosterone enanthate per week)
Trial: 25223181
Drug: Qingfei Peiyuan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qingfei Peiyuan Micro‐pill (QPM)
Trial: 25223181
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Western medicine only)
Trial: 15322960
Drug: Once-daily extended-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily extended-release methylphenidate
Trial: 15322960
Drug: Twice-daily immediate-release
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily immediate-release methylphenidate
Trial: 2994320
Drug: Preoperative therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative therapy (chemotherapy or radiotherapy)
Trial: 3280589
Drug: Domperidone (DMP)
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (DMP) administration
Trial: 31433919
Drug: Serelaxin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serelaxin (30 μg per kilogram of body weight per day) for 48 hours
Trial: 27786603
Drug: Clopidogrel (18.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (18.75 mg/cat q24h for seven days)
Trial: 25394856
Drug: Glycine air‐powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycine air‐powder system (SGA) adjuncted to professional oral hygiene (POH)
Trial: 25394856
Drug: Professional oral
RxNorm normalized name: Dentek Professional Oral Care Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Professional oral hygiene (POH)
Trial: 22581270
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (n = 111)
Trial: 21736844
Drug: Lupin beverage
RxNorm normalized name: Lupinus albus seed oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lupin beverage (50 g glucose + 12.5 g fibre + 22 g protein)
Trial: 21736844
Drug: Soya beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soya beverage (50 g glucose + 12.5 g fibre + 22 g protein)
Trial: 20101858
Drug: High-dose misoprostol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose misoprostol (maximum total dose 1400 g)
Trial: 20101858
Drug: Low-dose misoprostol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose misoprostol (maximum total dose 1400 g)
Trial: 3079695
Drug: High-dose misoprostol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose misoprostol
Trial: 3079695
Drug: Low-dose misoprostol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose misoprostol
Trial: 20166794
Drug: Aripiprazole 30
RxNorm normalized name: aripiprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole 30 mg/day
Trial: 15551047
Drug: Losartan, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan, 100 mg once daily
Trial: 8393058
Drug: Foscarnet 90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foscarnet 90 mg/kg/day infusion administered over 2 h
Trial: 8393058
Drug: Foscarnet 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foscarnet 120 mg/kg/day infusion administered over 2 h
Trial: 2883129
Drug: Terfenadine (H1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine (H1 histamine receptor antagonist)
Trial: 29870736
Drug: pyrimethamine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pyrimethamine (50 mg qd) + sulfadiazine (1 g tid) with folinic acid
Trial: 29870736
Drug: spiramycin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: spiramycin (1 g tid)
Trial: 19553184
Drug: Ciprofloxacin tablets
RxNorm normalized name: Ciprofloxacin Tablets
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin tablets
Trial: 15911730
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of simvastatin plus 15 g of psyllium (Metamucil) daily
Trial: 15911730
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of simvastatin plus placebo
Trial: 15911730
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of simvastatin plus placebo
Trial: 8602988
Drug: rhEPO (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhEPO (2 x 300 U/kg) and parenteral iron (2 x 200mg) with a 72 h interval
Trial: 8602988
Drug: rhEPO (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhEPO (2 x 300 U/kg) and parenteral iron (2 x 200mg) with a 24 h interval
Trial: 8602988
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received parenteral iron only
Trial: 24625805
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of inactivated EV71 vaccine (160 U, 320 U, and 640 U with adjuvant and 640 U without adjuvant)
Trial: 12058997
Drug: Polymyxin B
RxNorm normalized name: Polymyxin B
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Polymyxin B immobilized fiber (PMX‐F) treatment
Trial: 12058997
Drug: Septic trauma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Septic trauma patients before treatment
Trial: 12058997
Drug: Septic trauma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Septic trauma patients after treatment
Trial: 3545718
Drug: Sucralfate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (1 g qid)
Trial: 7697902
Drug: Mucosal-coating compounds
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mucosal-coating compounds
Trial: 7697902
Drug: Gastric antisecretory
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastric antisecretory drugs
Trial: 241932
Drug: Betaket (combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaket (combination of beta-receptor blocker and isosorbide dinitrate)
Trial: 241932
Drug: Betadrenol (beta-receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betadrenol (beta-receptor blocker)
Trial: 241932
Drug: Isoket (isosorbide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoket (isosorbide dinitrate preparation)
Trial: 22921680
Drug: Antiplatelet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet therapy (n=72), administered 24 hours after rt-PA for 10 days
Trial: 22921680
Drug: Non-antiplatelet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-antiplatelet therapy (n=74), received no antiplatelet therapy
Trial: 15920051
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin spray (20 puffs)
Trial: 15920051
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin spray (5, 10, and 20 puffs)
Trial: 15920051
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin spray
Trial: 15983312
Drug: Subcutaneous regular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous regular insulin
Trial: 9700963
Drug: 0 drops
RxNorm normalized name: MENTHOL 2.7 mg ORAL SUSPENSION/ DROPS [FREEGELLS COUGH DROPS MENTHOL STRAWBERRY 30 DROPS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 drops of corn syrup solution
Trial: 9700963
Drug: 1 drop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 drop of corn syrup solution
Trial: 9700963
Drug: 2 drops
RxNorm normalized name: CHOLECALCIFEROL 12.5 ug in 0.04 mL / MENAQUINONE 7 50 ug in 0.04 mL ORAL SOLUTION/ DROPS [YYUX Organic Liquid Vitamin D3 plus K2 Drops]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 drops of corn syrup solution
Trial: 9700963
Drug: 3 drops
RxNorm normalized name: UpSpring WellBaby DHA + Vitamin D3 Drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 drops of corn syrup solution
Trial: 6892479
Drug: Lysine‐8‐vasopressin (LVP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lysine‐8‐vasopressin (LVP) 5 I.U. administered intranasally daily for 5 days
Trial: 6892479
Drug: NaCl administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaCl administered intranasally daily for 5 days (control group)
Trial: 22384088
Drug: Single bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single bolus injection of erythropoietin, acute effects studied for 1-10 hours.